239 related articles for article (PubMed ID: 28043131)
1. Frozen in Time: Kinetically Stabilized Amorphous Solid Dispersions of Nifedipine Stable after a Quarter Century of Storage.
Theil F; Anantharaman S; Kyeremateng SO; van Lishaut H; Dreis-Kühne SH; Rosenberg J; Mägerlein M; Woehrle GH
Mol Pharm; 2017 Jan; 14(1):183-192. PubMed ID: 28043131
[TBL] [Abstract][Full Text] [Related]
2. Extraordinary Long-Term-Stability in Kinetically Stabilized Amorphous Solid Dispersions of Fenofibrate.
Theil F; Milsmann J; Kyeremateng SO; Anantharaman S; Rosenberg J; van Lishaut H
Mol Pharm; 2017 Dec; 14(12):4636-4647. PubMed ID: 29111751
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
4. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Amorphous Solid Dispersions and Identification of Low Levels of Crystallinity by Transmission Electron Microscopy.
S'ari M; Blade H; Cosgrove S; Drummond-Brydson R; Hondow N; Hughes LP; Brown A
Mol Pharm; 2021 May; 18(5):1905-1919. PubMed ID: 33797925
[TBL] [Abstract][Full Text] [Related]
6. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
7. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers.
Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH
Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546
[TBL] [Abstract][Full Text] [Related]
8. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
9. Spray-dried solid dispersions of nifedipine and vinylcaprolactam/vinylacetate/PEG₆₀₀₀ for compacted oral formulations.
Soulairol I; Tarlier N; Bataille B; Cacciaguerra T; Sharkawi T
Int J Pharm; 2015 Mar; 481(1-2):140-7. PubMed ID: 25579869
[TBL] [Abstract][Full Text] [Related]
10. Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia.
Martínez-Jiménez C; Cruz-Angeles J; Videa M; Martínez LM
Molecules; 2018 Aug; 23(9):. PubMed ID: 30154310
[TBL] [Abstract][Full Text] [Related]
11. Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation?
Singh A; Bharati A; Frederiks P; Verkinderen O; Goderis B; Cardinaels R; Moldenaers P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2016 Jun; 13(6):1879-93. PubMed ID: 27092396
[TBL] [Abstract][Full Text] [Related]
12. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
Aucamp M; Milne M; Liebenberg W
AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
[TBL] [Abstract][Full Text] [Related]
13. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
Abu-Diak OA; Jones DS; Andrews GP
J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
[TBL] [Abstract][Full Text] [Related]
14. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
15. Co-Stabilization of Amorphous Pharmaceuticals-The Case of Nifedipine and Nimodipine.
Knapik-Kowalczuk J; Tu W; Chmiel K; Rams-Baron M; Paluch M
Mol Pharm; 2018 Jun; 15(6):2455-2465. PubMed ID: 29738666
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of azithromycin--Aerosil 200 solid dispersions with enhanced physical stability.
Li X; Peng H; Tian B; Gou J; Yao Q; Tao X; He H; Zhang Y; Tang X; Cai C
Int J Pharm; 2015; 486(1-2):175-84. PubMed ID: 25794608
[TBL] [Abstract][Full Text] [Related]
17. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
[TBL] [Abstract][Full Text] [Related]
18. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
19. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
Huang J; Wigent RJ; Schwartz JB
J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
[TBL] [Abstract][Full Text] [Related]
20. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method.
Zajc N; Obreza A; Bele M; Srcic S
Int J Pharm; 2005 Mar; 291(1-2):51-8. PubMed ID: 15707731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
